| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
20,850 |
17,426 |
$3.24M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
11,574 |
9,518 |
$1.55M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
4,890 |
4,367 |
$790K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,516 |
3,682 |
$617K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,914 |
2,535 |
$468K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,939 |
2,427 |
$408K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,719 |
1,452 |
$402K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
7,462 |
1,951 |
$329K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
925 |
858 |
$262K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,437 |
1,321 |
$251K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,550 |
1,312 |
$238K |
| G0378 |
Hospital observation service, per hour |
2,014 |
1,053 |
$181K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,663 |
3,076 |
$131K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,631 |
520 |
$78K |
| 80053 |
Comprehensive metabolic panel |
17,966 |
14,420 |
$75K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
311 |
273 |
$67K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,890 |
1,381 |
$61K |
| 71046 |
Radiologic examination, chest; 2 views |
3,162 |
2,684 |
$59K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
582 |
532 |
$52K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,674 |
1,474 |
$44K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
392 |
351 |
$34K |
| 85027 |
|
23,101 |
17,658 |
$31K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
560 |
522 |
$23K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
6,397 |
5,053 |
$22K |
| 97161 |
|
243 |
225 |
$20K |
| 71045 |
Radiologic examination, chest; single view |
6,819 |
5,473 |
$19K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
8,562 |
6,940 |
$18K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,822 |
3,399 |
$17K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
8,464 |
6,513 |
$17K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
725 |
671 |
$16K |
| 36415 |
Collection of venous blood by venipuncture |
9,726 |
8,264 |
$15K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
94 |
83 |
$14K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
240 |
193 |
$14K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
33 |
28 |
$13K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,706 |
3,671 |
$13K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,961 |
680 |
$12K |
| 87040 |
|
2,261 |
1,650 |
$12K |
| 72100 |
|
596 |
531 |
$11K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
640 |
507 |
$11K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,622 |
2,365 |
$10K |
| 80061 |
Lipid panel |
3,198 |
2,943 |
$9K |
| 73630 |
|
495 |
451 |
$9K |
| 93017 |
|
76 |
68 |
$8K |
| 84484 |
|
6,389 |
4,574 |
$8K |
| 83880 |
|
1,784 |
1,445 |
$7K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
62 |
61 |
$7K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
589 |
549 |
$6K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
22 |
15 |
$6K |
| 73030 |
|
396 |
340 |
$6K |
| 81001 |
|
8,176 |
6,721 |
$5K |
| 85379 |
|
1,308 |
1,111 |
$5K |
| 97164 |
|
25 |
24 |
$5K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,449 |
3,567 |
$5K |
| 73562 |
|
291 |
270 |
$4K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,890 |
2,380 |
$4K |
| 80076 |
|
1,941 |
1,654 |
$4K |
| 93971 |
|
38 |
36 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,709 |
3,587 |
$3K |
| 83605 |
|
2,682 |
2,110 |
$3K |
| 73610 |
|
404 |
371 |
$3K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
335 |
297 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,007 |
3,117 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
46 |
40 |
$3K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
7,389 |
5,698 |
$3K |
| 85610 |
|
4,170 |
3,271 |
$2K |
| 83735 |
|
4,125 |
3,258 |
$2K |
| 80143 |
|
753 |
670 |
$2K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
400 |
110 |
$2K |
| 97162 |
|
42 |
37 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
7,632 |
3,429 |
$2K |
| 87070 |
|
2,289 |
2,078 |
$2K |
| 83690 |
|
4,690 |
3,894 |
$2K |
| 81003 |
|
3,855 |
3,334 |
$2K |
| 93246 |
|
41 |
40 |
$2K |
| 87420 |
|
570 |
539 |
$2K |
| 81025 |
|
3,442 |
2,991 |
$2K |
| 74018 |
|
79 |
67 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,725 |
4,513 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,976 |
1,525 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
4,615 |
4,224 |
$1K |
| 80047 |
|
484 |
368 |
$1K |
| 80179 |
|
757 |
677 |
$1K |
| 87186 |
|
1,125 |
921 |
$1K |
| 72114 |
|
42 |
35 |
$1K |
| 76830 |
Ultrasound, transvaginal |
12 |
12 |
$982.51 |
| 73502 |
|
58 |
50 |
$796.61 |
| 85730 |
|
894 |
757 |
$711.26 |
| 93226 |
|
14 |
13 |
$638.96 |
| 86140 |
|
367 |
321 |
$632.17 |
| 84439 |
|
117 |
108 |
$621.89 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,399 |
2,273 |
$620.83 |
| 85652 |
|
307 |
275 |
$587.18 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
504 |
406 |
$582.79 |
| 96376 |
|
563 |
421 |
$541.65 |
| 72110 |
|
49 |
36 |
$540.50 |
| 74021 |
|
18 |
16 |
$530.20 |
| 82077 |
|
1,316 |
1,146 |
$466.81 |
| 84703 |
|
595 |
537 |
$408.56 |
| 90714 |
|
19 |
16 |
$404.93 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
606 |
481 |
$401.87 |
| 87077 |
|
770 |
655 |
$373.09 |
| 73110 |
|
25 |
24 |
$344.50 |
| 82607 |
|
27 |
25 |
$291.00 |
| 71250 |
|
13 |
13 |
$281.05 |
| 82550 |
|
820 |
710 |
$272.13 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,390 |
1,060 |
$233.82 |
| 84702 |
|
53 |
36 |
$228.78 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,023 |
808 |
$190.46 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
30 |
24 |
$176.29 |
| 86850 |
|
50 |
42 |
$132.78 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
74 |
68 |
$128.72 |
| 73130 |
|
69 |
66 |
$117.48 |
| 82803 |
|
295 |
244 |
$105.10 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,102 |
833 |
$81.23 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
655 |
563 |
$50.31 |
| J7050 |
Infusion, normal saline solution, 250 cc |
626 |
408 |
$47.65 |
| 86900 |
|
29 |
25 |
$42.03 |
| 84100 |
|
50 |
38 |
$40.56 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
103 |
54 |
$23.51 |
| 86901 |
|
29 |
25 |
$22.35 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
140 |
102 |
$18.66 |
| 82248 |
|
30 |
27 |
$17.85 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
446 |
408 |
$15.83 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
372 |
281 |
$15.68 |
| 87147 |
|
39 |
37 |
$15.01 |
| J1630 |
Injection, haloperidol, up to 5 mg |
50 |
43 |
$12.13 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
368 |
247 |
$11.09 |
| J1815 |
Injection, insulin, per 5 units |
334 |
157 |
$8.06 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
34 |
26 |
$5.44 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
134 |
108 |
$3.34 |
| A9270 |
Non-covered item or service |
2,837 |
688 |
$3.20 |
| 82310 |
|
23 |
18 |
$3.07 |
| J1644 |
Injection, heparin sodium, per 1000 units |
26 |
14 |
$2.49 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
25 |
15 |
$1.84 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
67 |
36 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
45 |
38 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
76 |
63 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
190 |
151 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
12 |
12 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
12 |
12 |
$0.00 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
26 |
13 |
$0.00 |
| J3490 |
Unclassified drugs |
646 |
538 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
178 |
135 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
90 |
81 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
33 |
28 |
$0.00 |
| 87081 |
|
33 |
32 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
70 |
66 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
20 |
18 |
$0.00 |